Invention Grant
- Patent Title: Glucagon/GLP-1 agonists for the treatment of obesity
-
Application No.: US15673826Application Date: 2017-08-10
-
Publication No.: US10556939B2Publication Date: 2020-02-11
- Inventor: Balaji Agoram , Madeleine Antonsson , Maria A. Bednarek , Nicole Burmeister , Lambertus Benthem , David Fairman , Maria Fritsch-Fredin , Ronald Jackson , Rasmus Jansson Lofmark , Jacqueline Metcalfe
- Applicant: MedImmune Limited
- Applicant Address: GB Cambridge
- Assignee: MEDIMMUNE LIMITED
- Current Assignee: MEDIMMUNE LIMITED
- Current Assignee Address: GB Cambridge
- Main IPC: A61K38/26
- IPC: A61K38/26 ; C07K14/605 ; A61K38/00
Abstract:
This disclosure provides GLP-1/glue agon agonist peptides for the treatment of metabolic diseases, e.g., obesity.
Public/Granted literature
- US20170342121A1 GLUCAGON/GLP-1 AGONISTS FOR THE TREATMENT OF OBESITY Public/Granted day:2017-11-30
Information query
IPC分类:
